ACARIZAX Receives Marketing Authorization in France
January 27, 2016 at 04:13 AM EST
ALK (OTC: AKBLF) today announced that authorities in France, the world's biggest sublingual allergy immunotherapy market, have issued a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.